Cytokine profile and pathology in human leishmaniasis

Lainson R, 1978, Epidemiology and ecology of leishmaniasis in Latin-America, Nature, 273, 595, 10.1038/273595a0

Marsden PD, 1979, Current concepts in parasitology: Leishmaniasis, New England Journal of Medicine, 300, 350, 10.1056/NEJM197902153000706

Barral A, 1991, Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease, American Journal of Tropical Medicine and Hygiene, 44, 536, 10.4269/ajtmh.1991.44.536

Grimaldi GJ, 1987, Identification and distribution of New World Leishmania species characterized by serodeme analysis using monoclonal antibodies, American Journal of Tropical Medicine and Hygiene, 36, 270, 10.4269/ajtmh.1987.36.270

Grimaldi GJ, 1991, Characterization and classification of leishmanial parasites from humans, wild mammals, and sand flies in the Amazon region of Brazil, American Journal of Tropical Medicine and Hygiene, 44, 645, 10.4269/ajtmh.1991.44.645

Convit J, 1972, Diffuse cutaneous leishmaniasis: A disease due to an immunological defect of the host, Transactions of the Royal Society of Tropical Medicine and Hygiene, 66, 603, 10.1016/0035-9203(72)90306-9

Badaró R, 1986, Leishmania donovani: An opportunistic microbe associated with progressive disease in three immunocompromised patients, Lancet, 1, 647, 10.1016/S0140-6736(86)91725-3

Scott P, 1991, Interferon gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis, Journal of Immunology, 147, 3149, 10.4049/jimmunol.147.9.3149

Heinzel FP, 1989, Reciprocal expression of IFN-<FONT FACE="Symbol">g</font> or IL-4 during the resolution or progression of murine leishmaniasis: Evidence for expression of distinct helper T cell subsets, Journal of Experimental Medicine, 169, 59, 10.1084/jem.169.1.59

Heinzel FP, 1991, Production of IFN-<FONT FACE="Symbol">g</font>, IL-2, IL-4 and IL-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis, Proceedings of the National Academy of Sciences, USA, 80, 7011, 10.1073/pnas.88.16.7011

Chatelain R, 1992, Interleukin-4 induces a Th2 response in L. major infected mice, Journal of Immunology, 148, 1182, 10.4049/jimmunol.148.4.1182

Belosevic M, 1989, Administration of monoclonal anti IFN-<FONT FACE="Symbol">g</font> antibodies in vivo abrogates natural resistance of C3H/NeN mice to infection with Leishmania major, Journal of Immunology, 143, 266, 10.4049/jimmunol.143.1.266

Carvalho EM, 1992, Immunologic markers of clinical evolution in children recently infected with L. donovani chagasi, Journal of Infectious Diseases, 165, 535, 10.1093/infdis/165.3.535

Zwingenberger K, 1990, Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-<FONT FACE="Symbol">g</font> production, Clinical Immunology and Immunopathology, 57, 242, 10.1016/0090-1229(90)90038-R

Ghalib HW, 1993, Interleukin-10 production correlates with pathology in human Leishmania donovani infections, Journal of Clinical Investigation, 92, 324, 10.1172/JCI116570

Karp CL, 1993, Journal of Clinical Investigation, 91, 1644, 10.1172/JCI116372

Holaday BJ, 1993, Potential role for IL-10 in the immune suppression associated with kala-azar, Journal of Clinical Investigation, 92, 2626, 10.1172/JCI116878

Carvalho EM, 1994, Restoration of IFN-<FONT FACE="Symbol">g</font> production and lymphocyte proliferation in visceral leishmaniasis, Journal of Immunology, 152, 5949, 10.4049/jimmunol.152.12.5949

Ghalib HW, 1995, Interleukin-12 enhances Th1 type immune response in human Leishmania donovani infection, Journal of Immunology, 154, 4623, 10.4049/jimmunol.154.9.4623

Bacellar O, 1996, Interleukin-12 restores interferon-<FONT FACE="Symbol">g</font> production and cytotoxic responses in visceral leishmaniasis, Journal of Infectious Diseases, 173, 1515, 10.1093/infdis/173.6.1515

Bogdan C, 1991, Macrophage deactivation by IL-10, Journal of Experimental Medicine, 174, 1549, 10.1084/jem.174.6.1549

Castés M, 1983, Characterization of the cellular immune response in American cutaneous leishmaniasis, Clinical Immunology and Immunopathology, 27, 176, 10.1016/0090-1229(83)90068-5

Carvalho EM, 1985, Cell mediated immunity in American cutaneous and mucosal leishmaniasis, Journal of Immunology, 135, 4144, 10.4049/jimmunol.135.6.4144

Coutinho SG, 1987, Pathogenesis and immunopathology of leishmaniasis, Memórias do Instituto Oswaldo Cruz, 82, 214, 10.1590/S0074-02761987000500005

Mendonça SCF, 1986, Human American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) in Brazil: lymphoproliferative response and influence of therapy, Clinical and Experimental Immunology, 64, 269

Pirmez C, 1993, Cytokine patterns in the pathogenesis of human leishmaniasis, Journal of Clinical Investigation, 91, 1390, 10.1172/JCI116341

Cáceres-Dittmar G, 1993, Determination of the cytokine profile in American cutaneous leishmaniasis using polymerase chain reaction, Clinical and Experimental Immunology, 91, 500, 10.1111/j.1365-2249.1993.tb05931.x

Melby PC, 1994, Increased expression of pro-inflammatory cytokines in chronic lesions of human cutaneous leishmaniasis, Infection and Immunity, 62, 837, 10.1128/IAI.62.3.837-842.1994

Almeida RP, 1995, Evaluation of cellular immune responses in patients with different clinical forms of tegumentary leishmaniasis, Allergy Journal of Immunology, 14, 11

Castés M, 1993, Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis, Biological Research, 26, 233

Da-Cruz AM, 1996, Tumor necrosis factor-alpha in human American tegumentary leishmaniasis, Memórias do Instituto Oswaldo Cruz, 91, 225, 10.1590/S0074-02761996000200019

Strieter RM, 1988, Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline, Biochemical and Biophysical Research Communications, 153, 1230, 10.1016/S0006-291X(88)81271-3

Doherty GM, 1991, Pentoxifylline suppression of tumor necrosis factor gene transcription, Surgery, 110, 192

Liew FY, 1990, Tumor necrosis factor <FONT FACE="Symbol">a</font> synergizes with IFN-<FONT FACE="Symbol">g</font> in mediating killing of Leishmania major through the induction of nitric oxide, Journal of Immunology, 145, 4306, 10.4049/jimmunol.145.12.4306

Liew FY, 1990, Tumor necrosis factor (TNF-<FONT FACE="Symbol">a</font>) in leishmaniasis: I. TNF-<FONT FACE="Symbol">a</font> mediates host protection against cutaneous leishmaniasis, Immunology, 69, 570

Titus RG, 1989, Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis, Journal of Experimental Medicine, 170, 2097, 10.1084/jem.170.6.2097

Carvalho EM, 1995, Characterization of the immune response in subjects with self healing cutaneous leishmaniasis, American Journal of Tropical Medicine and Hygiene, 53, 273, 10.4269/ajtmh.1995.53.273